
Acadia Healthcare Company, Inc. (ACHC)
$
23.44
+1.15 (4.91%)
Key metrics
Financial statements
Free cash flow per share
-4.8640
Market cap
2.1 Billion
Price to sales ratio
0.6400
Debt to equity
1.3562
Current ratio
1.5502
Income quality
-0.1208
Average inventory
3.1 Million
ROE
-0.3942
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States and Puerto Rico, highlighting the company's operational efficiency with an EBITDA ratio of 0.17. The company's stock is identified with the symbol 'ACHC' in the market, allowing investors to track its performance effectively. Acadia reported a substantial revenue of $3,312,769,000.00 reflecting its strong market presence and ability to cater to diverse patient needs. The income before tax ratio stands at -0.32 illustrating the pre-tax margin and underlying profitability. Moreover, the company reported selling, general, and administrative expenses of $195,475,000.00 indicating its operational overhead costs as it manages a network of facilities that includes inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, Acadia operates 238 behavioral healthcare facilities with approximately 10,600 beds, demonstrating its commitment to offering comprehensive healthcare solutions. The stock is affordable at $22.14 making it suitable for budget-conscious investors looking for entry points in the market. With a high average trading volume of 3,796,504.00 the stock indicates strong liquidity, which appeals to active traders and long-term investors alike. With a mid-range market capitalization of $2,120,013,478.00 the company is a steady performer amidst market fluctuations. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape, addressing the growing need for mental health services. Acadia Healthcare belongs to the Healthcare sector, driving innovation and growth as it advances its mission to provide quality care and improve outcomes for its patients. This essential role in the behavioral healthcare field positions it favorably for continued success and relevance in a rapidly evolving industry.
Investing in Acadia Healthcare Company, Inc. (ACHC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Acadia Healthcare Company, Inc. stock to fluctuate between $11.43 (low) and $31.43 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-02-27, Acadia Healthcare Company, Inc.'s market cap is $2,120,013,478, based on 90,444,261 outstanding shares.
Compared to Eli Lilly & Co., Acadia Healthcare Company, Inc. has a Lower Market-Cap, indicating a difference in performance.
To buy Acadia Healthcare Company, Inc. (ACHC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ACHC. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Acadia Healthcare Company, Inc.'s last stock split was 1:4 on 2011-11-01.
Revenue: $3,312,769,000 | EPS: -$12.16 | Growth: -535.84%.
Visit https://www.acadiahealthcare.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $89.85 (2022-11-30) | All-time low: $11.43 (2026-01-15).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

seekingalpha.com
Acadia Healthcare Company, Inc. maintains a Buy rating as new CEO Debbie Osteen focuses on operational stability and disciplined capital allocation amid ongoing industry headwinds. ACHC 2025 revenues reached $3.3bn with adjusted EBITDA of $609m, but a net loss of $1.1bn was driven by a non-cash goodwill impairment. 2026 guidance projects modest revenue growth to $3.37–$3.45bn, adjusted EBITDA of $575–$610m, and EPS decline, reflecting a reset year with limited organic volume growth.

seekingalpha.com
Acadia Healthcare Company, Inc. (ACHC) Q4 2025 Earnings Call Transcript

benzinga.com
The stock is moving higher as the broader market is experiencing gains, with the Nasdaq up 1.23%.

seekingalpha.com
Acadia Healthcare is rated Buy, driven by a record-low valuation post-2011 merger and a massive 29% short interest poised for a potential squeeze. ACHC trades at 6.5x EV/EBITDA and 1.2x EV/sales, far below its 10-year medians and current peer ratios, with steady earnings projected during 2026-27. Management slashed CapEx by $300M for 2026, aiming to stabilize cash flows and address debt concerns, while a new CEO and activist investors add confidence in a turnaround.

businesswire.com
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & Associates' 47th Annual Institutional Investors Conference, being held March 1-4, 2026, in Orlando, Florida. The Company's presentation/fireside chat will begin at 11:35 a.m. Eastern Time/10:35 a.m. Central Time. On Monday, March 9, 2026, the Com.

seekingalpha.com
Acadia Healthcare Company, Inc. (ACHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

fool.com
New York City-based Engine Capital Management initiated a stake in Acadia Healthcare during the third quarter, acquiring nearly 2.6 million shares worth $64 million. The change represents 7.6% of reportable U.S. equity assets under management.

businesswire.com
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ACADIA HEALTHCARE COMPANY, INC. (ACHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss.

proactiveinvestors.com
Acadia Healthcare (NASDAQ:ACHC) shares plunged more than 10% after the company was downgraded to an ‘Underperform' rating by Bank of America analysts, who warned that rising insurance and legal costs will pressure profitability into 2026. The analyst also lowered their price objective on Acadia Healthcare to $13.

businesswire.com
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ACADIA HEALTHCARE COMPANY, INC. (ACHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On December 2, 2025, after market hours, A.
See all news